Elgemtumab
Elgemtumab (LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential[1].
Product Specifications
CAS Number
1512559-37-3
Product Name Alternative
LJM716
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/elgemtumab.html
Purity
99.00
Solubility
10 mM in DMSO
Smiles
[Elgemtumab]
Molecular Weight
(143.977 kDa)
References & Citations
[1]Andrew P Garner, et al. An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin. Cancer Res. 2013 Oct 1;73 (19) :6024-35.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC219096L4V 200 µL
ESPNL (NM_194312) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 